Table 6.
Biological and disease relevance activity | Decreased biomarker activity | Increased biomarker activity | Modulated activity* |
---|---|---|---|
3R4F | |||
Inflammation-related activities | MIP-1, sTNFα, VCAM-1, Eot3 | sPGE2, IL-1α, IL-8 | _ |
Immunomodulatory activities | M−CSF, sIL-10, sIL-2, sIL-6, CD40, sIL-17A | – | _ |
Tissue remodeling activities | – | EGFR | _ |
Haemostasis-related activities | – | TM, TF | _ |
HTP | |||
Immunomodulatory activities | M−CSF | sIL-10 | _ |
Tissue remodeling activities | EGFR | – | _ |
HYB | |||
Tissue remodeling activities | – | EGFR | _ |
EVP | |||
Immunomodulatory activities | – | sIL-10 | _ |
Tissue remodeling activities | EGFR, Col-I | – | _ |
*Biomarker key activities were described as modulated if these activities increased in some systems but decreased in others.